These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

964 related items for PubMed ID: 9610754

  • 1. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 3. Insulin-like growth factor binding proteins 4 and 5 and bone mineral density in elderly men and women.
    Karasik D, Rosen CJ, Hannan MT, Broe KE, Dawson-Hughes B, Gagnon DR, Wilson PW, Visser M, Langlois JA, Mohan S, Kiel DP.
    Calcif Tissue Int; 2002 Oct; 71(4):323-8. PubMed ID: 12202958
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone-dependent insulin-like growth factor binding protein is a major determinant of bone mineral density in healthy men.
    Johansson AG, Forslund A, Hambraeus L, Blum WF, Ljunghall S.
    J Bone Miner Res; 1994 Jun; 9(6):915-21. PubMed ID: 7521562
    [Abstract] [Full Text] [Related]

  • 5. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F.
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [Abstract] [Full Text] [Related]

  • 6. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 7. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Sep; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the components of the insulin-like growth factors system in GH-deficient adults: effects of twelve-month rhGH treatment.
    Ferrante E, Giavoli C, Porretti S, Vassallo E, Ronchi CL, Lania AG, Beck-Peccoz P, Spada A.
    Horm Metab Res; 2006 May; 38(5):352-5. PubMed ID: 16718634
    [Abstract] [Full Text] [Related]

  • 9. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy.
    Fernholm R, Thoren M, Hoybye C, Anderstam B, Pernow Y, Saaf M, Hall K.
    Growth Horm IGF Res; 2009 Jun; 19(3):206-11. PubMed ID: 18990596
    [Abstract] [Full Text] [Related]

  • 10. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [Abstract] [Full Text] [Related]

  • 11. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ, Khosla S.
    J Bone Miner Res; 2004 Jul; 19(7):1075-83. PubMed ID: 15176989
    [Abstract] [Full Text] [Related]

  • 12. Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone.
    Ehrnborg C, Ohlsson C, Mohan S, Bengtsson BA, Rosén T.
    Growth Horm IGF Res; 2007 Jun; 17(3):234-41. PubMed ID: 17347011
    [Abstract] [Full Text] [Related]

  • 13. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M, Müller J, Svendsen OL, Kastrup KW, Juul A, Feldt-Rasmussen U.
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [Abstract] [Full Text] [Related]

  • 14. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males.
    Svensson J, Ohlsson C, Jansson JO, Murphy G, Wyss D, Krupa D, Cerchio K, Polvino W, Gertz B, Baylink D, Mohan S, Bengtsson BA.
    J Bone Miner Res; 1998 Jul; 13(7):1158-66. PubMed ID: 9661080
    [Abstract] [Full Text] [Related]

  • 15. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
    Magnusson P, Degerblad M, Sääf M, Larsson L, Thorén M.
    J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
    [Abstract] [Full Text] [Related]

  • 16. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
    Kuzma M, Payer J.
    Cas Lek Cesk; 2010 Feb; 149(5):211-6. PubMed ID: 20629339
    [Abstract] [Full Text] [Related]

  • 17. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
    Colao A, Di Somma C, Pivonello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Corneli G, Ghigo E, Lombardi G.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
    [Abstract] [Full Text] [Related]

  • 18. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [Abstract] [Full Text] [Related]

  • 20. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
    Janssen YJ, Hamdy NA, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.